Skip to search.
 TSX Down 0.04% TSX Ventures Down 0.04%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
451.48 Down 8.30(1.81%) 4:00PM EDT
|After Hours : 450.00 Down 1.48 (0.33%) 7:32PM EDT
Add to Portfolio
Prev Close:459.78
Open:456.23
Bid:N/A
Ask:457.00 x 100
1y Target Est:450.26
Beta:0.69
Earnings Date:May 6 - May 11 (Est.)
Day's Range:450.02 - 464.52
52wk Range:269.50 - 495.50
Volume:885,141
Avg Vol (3m):894,236
Market Cap:46.00B
P/E (ttm):147.06
EPS (ttm):3.07
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNDown 1.81%46.00B
AMGNDown 2.71%121.30B
NVSDown 2.67%236.53B
RHHBYUp 0.50%N/A

Key Statistics

Forward P/E (1 yr):35.66
P/S (ttm):16.61
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :10.90
Quarterly EPS Est (Mar-15) :2.69
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):2.24

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback